Filter
1719
Filtered Results: 1719
Text search:
European
Medicines
Agency
Featured
Recommendations
161
New Publications
353
Language
Document type
No document type
799
Studies & Reports
412
Guidelines
252
Manuals
107
Strategic & Response Plan
56
Fact sheets
38
Training Material
22
Situation Updates
21
Resource Platforms
5
Brochures
4
App
1
Infographics
1
Online Courses
1
Countries / Regions
Global
94
Western and Central Europe
94
Ukraine
55
Eastern Europe
35
Africa
29
Kenya
28
Ethiopia
25
Ghana
21
Sierra Leone
21
Nigeria
21
Zambia
21
Germany
19
Liberia
19
Myanmar / Burma
19
Nepal
18
Syria
18
Latin America and the Carribbean
18
India
18
Eastern Europe and Central Asia
17
Russia
16
South Africa
15
Guinea
12
South–East Asia Region
12
Philippines
11
Venezuela
11
West and Central Africa
11
Bangladesh
11
Uganda
11
Rwanda
10
Moldova
10
Malawi
9
Zimbabwe
9
East and Southern Africa
9
Tajikistan
8
Senegal
8
Congo, Democratic Republic of
8
Namibia
8
Thailand
7
Tanzania
7
Georgia
7
Indonesia
7
North Macedonia
6
Colombia
6
Burkina Faso
6
Jordan
6
Middle East and North Africa
6
Brazil
6
South Sudan
6
Cameroon
5
Albania
5
Mozambique
5
Cambodia
5
Asia
5
Paraguay
5
Yemen
5
Eswatini/ Swaziland
5
Benin
4
Haiti
4
Hungary
4
Sudan
4
Poland
4
Botswana
4
Somalia
4
Serbia
3
Lesotho
3
Turkey
3
China
3
Kazakhstan
3
Laos
3
Kyrgyzstan
3
Afghanistan
3
USA
3
Jamaica
3
Belarus
3
Lebanon
3
Vietnam
3
Romania
3
Pakistan
3
Chile
2
Iran
2
Estonia
2
Uzbekistan
2
Morocco
2
Bulgaria
2
Western Pacific Region
2
Bosnia and Herzegovina
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Argentina
2
Sri Lanka
2
Egypt
2
Central African Republic
2
Libya
2
Iraq
2
Madagascar
2
Mexico
1
El Salvador
1
Australia
1
Niger
1
Peru
1
Mongolia
1
Mauritania
1
Armenia
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Spain
1
Southern Africa
1
Papua New Guinea
1
Slovakia
1
Greece
1
Mali
1
Bhutan
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
427
Clinical Guidelines
158
Key Resources
104
Public Health
95
Women & Child Health
79
Pharmacy & Technologies
30
Capacity Building
14
Toolboxes
COVID-19
165
Mental Health
164
HIV
137
TB
125
AMR
111
Planetary Health
82
Conflict
74
Rapid Response
71
Pharmacy
59
Refugee
52
Disability
49
Ebola & Marburg
48
Global Health Education
42
NCDs
33
NTDs
32
Caregiver
31
Health Financing Toolbox
31
Specific Hazards
18
Natural Hazards
14
Zika
14
Polio
6
Cholera
3
Malaria
2
Social Ethics
1
Since the discovery of insulin nearly 100 years ago, advances in diabetes treatments and therapies have transformed the lives of people
with diabetes (PwD), notably reducing the daily burden of its management.
Newer technologies, including those driven by artificial intelligence, have the potentia...
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...
This guideline provides advice in regards to applications for Marketing Authorisations for antimicrobial veterinary medicinal products (VMPs) on the data required and the methodology to be used for performing an assessment of the risk to public health from antimicrobial resistance (AMR) due to use o...
Accessed November 2017
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages
18 Febr. 2021
The European Medicines Agency (EMA) is evaluating potential COVID-19 treatments and vaccines to enable promising medicines to reach patients as soon as possible. It is also interacting with medicine developers and making use of real-world data to monitor the safety and effectiveness of medicines use...
23 April 2020EMA/202483/2020 Rev
Chloroquine and hydroxychloroquine are known to potentially cause heart rhythm problems, and these could be exacerbated if treatment is combined with other medicines, such as the antibiotic azithromycin, that have similar effects on the heart.
The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and antimicrobial resistance (AMR) in bacteria from humans and food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance networks for 2013–2015. AMC in both sectors, exp...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to ...
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge...
Migrants in an irregular situation: access to healthcare in 10 European Union Member States
recommended
This report explores the access to healthcare granted to irregular migrants in 10 EU Member States. It focuses on migrants who are present in an irregular situation, namely those who do not fulfil conditions for entry, stay or residence. Through interviews with a range of different sources including...
Community pharmacists are the health professionals most accessible to the public and are a cornerstone of primary health care. The role of community pharmacists is expanding globally. This report provides an overview of existing components and provisions of the legal and regulatory framework for com...
This report aims to estimate the economic cost of providing regular access to healthcare for migrants in an irregular situation, compared with the cost of providing treatment in emergency cases only. Two specific medical conditions – hypertension and prenatal care – were selected as examples, an...
This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air within and between the EU/EEA countries and the UK in the context of the COVID-19 pandemic, noting th...
Joint EUAA, IOM and OECD report provides new insights on displacement from and within Ukraine
The European Union Agency for Asylum (EUAA), the International Organization for Migration (IOM) and the Organisation for Economic Co-operation and Development (OECD) have published a Joint Report on profil...
